Literature DB >> 1648786

Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.

L Boström1, O Ringdén, M Forsgren.   

Abstract

Prior to bone marrow transplantation (BMT) titres of IgG antibodies for cytomegalovirus (CMV), herpes simplex virus (HSV) and varicella zoster virus (VZV) were analysed in 51 donors and recipients of allogeneic bone marrow. Donor mononuclear cells from peripheral blood and bone marrow cells were stimulated with antigen prepared from CMV, HSV and VZV. High IgG titres for HSV in the recipient were associated with grade II-III acute graft-versus-host disease (GVHD) (P = 0.05). Furthermore, the combination of positive IgG titre for HSV antibodies in the recipient, and strong donor blood mononuclear cell reactivity to HSV antigen in HSV immune donors, significantly increased the incidence of grade II-III acute GVHD (P = 0.04). The data suggest that HSV immune donor mononuclear cells may initiate a GVH reaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648786     DOI: 10.1111/j.1365-3083.1991.tb01519.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.

Authors:  J Mattsson; M Uzunel; M Remberger; L Tammik; B Omazic; V Levitsky; J Z Zou; P Hentschke; O Ringdén
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 2.  Current thoughts on the pathogenesis of graft versus host disease.

Authors:  A L Appleton; L Sviland
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

3.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

4.  Intensification of GVHD prophylaxis interferes with the effects of pretransplant herpes virus serology on the occurrence of grades II-IV acute graft-versus-host disease.

Authors:  J W Gratama; H vd Nat; H T Weiland; T Stijnen; W E Fibbe; J M Vossen; R Willemze; L F Verdonck
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.